Macciacchera Matthew, McDonnell Jake M, Amir Aisyah, Sowa Aubrie, Cunniffe Gráinne, Darwish Stacey, Murphy Ciara, Butler Joseph S
School of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
National Spinal Injuries Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
Global Spine J. 2025 Mar;15(2):1356-1366. doi: 10.1177/21925682241261988. Epub 2024 Jun 18.
Systematic review and meta-analysis.
Surgical management of osteoporotic vertebral compression fractures (OVCFs) has traditionally consisted of vertebroplasty or kyphoplasty procedures. Mechanical percutaneous vertebral body augmentation (MPVA) systems have recently been introduced as alternatives to traditional methods. However, the effectiveness of MPVA systems vs conventional augmentation techniques for OVCFs remains unclear. This serves as the premise for this study.
A systematic review and meta-analysis was conducted as per the guidelines. Studies of interest included randomized controlled trials (RCTs) which directly compared patient outcomes following kyphoplasty to patients treated with MPVA systems. Clinical and radiological findings were collated and compared for significance between cohorts.
6 RCTs were identified with 1024 patients total. The mean age of all patients was 73.5 years. 17% of the cohort were male, 83% were female. 515 patients underwent kyphoplasty and 509 underwent mechanical vertebral body augmentation using MPVA systems. MPVAs showed similar efficacy for restoration of vertebral body height ( = .18), total complications ( = .36), cement extravasation ( = .58) and device-related complications ( = .06). MPVAs also showed reduced rates of all new fractures (16.4% vs 22.2%; = .17) and adjacent fractures (14.7% vs 18.9%; = .23), with improved visual analogue scale (VAS) scores at 6-month ( = .13).
The results of this meta-analysis highlight no significant improvement in clinical or radiological outcomes for MPVA systems when compared to balloon kyphoplasty for vertebral body augmentation. Further research is needed to establish a true benefit over traditional operative methods.
系统评价与荟萃分析。
骨质疏松性椎体压缩骨折(OVCFs)的手术治疗传统上包括椎体成形术或后凸成形术。机械经皮椎体强化(MPVA)系统最近已被引入作为传统方法的替代方案。然而,MPVA系统与传统强化技术治疗OVCFs的有效性仍不明确。这是本研究的前提。
按照指南进行系统评价与荟萃分析。纳入的研究包括随机对照试验(RCTs),这些试验直接比较了后凸成形术与接受MPVA系统治疗的患者的结局。整理并比较了队列之间的临床和影像学结果的显著性。
共纳入6项RCTs,总计1024例患者。所有患者的平均年龄为73.5岁。队列中17%为男性,83%为女性。515例患者接受了后凸成形术,509例患者使用MPVA系统进行了机械椎体强化。MPVA在恢复椎体高度(P = 0.18)、总并发症(P = 0.36)、骨水泥渗漏(P = 0.58)和器械相关并发症(P = 0.06)方面显示出相似的疗效。MPVA还显示所有新发骨折(16.4%对22.2%;P = 0.17)和相邻骨折(14.7%对18.9%;P = 0.23)的发生率降低,6个月时视觉模拟评分(VAS)改善(P = 0.13)。
本荟萃分析的结果表明,与球囊后凸成形术进行椎体强化相比,MPVA系统在临床或影像学结局方面没有显著改善。需要进一步研究以确定其相对于传统手术方法的真正益处。